Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2023-08-18 00:00:00 ET · period of report 2023-08-18 · accession 0001415889-23-012411 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-18 | 2023-08-18 | FENC | RALLIS CHRIS A | Dir | S - Sale | $7.85 | -673 | 43.3K | -2% | -$5,283 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-08-18 | S | D | 673 | $7.85 | 43,303 | D | — | — | (F1) Shares originally acquired through the exercise of an option with strike price of $0.45, and an original expiration date of August 17, 2022. |